LAMPERTICO, PIETRO
LAMPERTICO, PIETRO
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Reappraisal of the conventional hemostasis tests as predictors of perioperative bleeding in the era of rebalanced hemostasis in cirrhosis
2024 A. Tripodi, M. Primignani, R. D'Ambrosio, G. Tosetti, V. La Mura, P. Lampertico, F. Peyvandi
Comprehensive investigation of platelet function in patients with cirrhosis
2024 A. Lecchi, G. Tosetti, C. Ghali, S. La Marca, M. Clerici, L. Padovan, E.A. Femia, M. Primignani, V. La Mura, P. Lampertico, F. Peyvandi, A. Tripodi
HDV RNA Assays: Performance characteristics, clinical utility and challenges
2023 H. Wedemeyer, M. Leus, T. R Battersby, J. Glenn, E. Gordien, S. Kamili, H. Kapoor, H. H Kessler, O. Lenz, M. Lütgehetmann, T. Mixson-Hayden, C. O Simon, M. Thomson, G. Westman, V. Miller, N. Terrault, P. Lampertico
Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitro
2023 M. Rossi, A. Vecchi, C. Tiezzi, V. Barili, P. Fisicaro, A. Penna, I. Montali, S. Daffis, S. Fletcher, A. Gaggar, J. Medley, M. Graupe, L. Lad, A. Loglio, R. Soffredini, M. Borghi, T. Pollicino, C. Musolino, A. Alfieri, F. Brillo, D. Laccabue, M. Massari, C. Boarini, G. Abbati, G. Pedrazzi, G. Missale, P. Lampertico, C. Ferrari, C. Boni
Carvedilol to reduce the risk of decompensation in patients with compensated cirrhosis: Is it really needed in patients with cured HCV or suppressed HBV?
2023 G. Tosetti, E. Degasperi, E. Farina, M. Primignani, P. Lampertico
Stesura di progetto internazionale di screening, vaccinazione e cura contro l'epatite C - Multi-country Viral Hepatitis COMmunity Screening, Vaccination, and Care (VH-COMSAVAC): Project outline
2023 A.M. Pezzullo, C.A. Picchio, L. Villani, D. Pascucci, R. Pastorino, M. Di Pumpo, A. Taha, L. Van Selm, D. Boudou, D. Fortin, G. Kalamitsis, M. Colombo, G. Colucci, P. Lampertico, A.G. De Belvis, C. La Vecchia, S. Boccia, J.V. Lazarus
Reproducibility and accuracy of a pocket-size ultrasound device in assessing liver steatosis
2023 A. Costantino, A. Piagnani, R. Caccia, A. Sorge, M. Maggioni, R. Perbellini, F. Donato, R. D'Ambrosio, N.P. O Sed, L. Valenti, D. Prati, M. Vecchi, P. Lampertico, M. Fraquelli
Deregulated intracellular pathways define novel molecular targets for HBV-specific CD8 T cell reconstitution in chronic hepatitis B
2023 I. Montali, C. Ceccatelli Berti, M. Morselli, G. Acerbi, V. Barili, G. Pedrazzi, B. Montanini, C. Boni, A. Alfieri, M. Pesci, A. Loglio, E. Degasperi, M. Borghi, R. Perbellini, A. Penna, D. Laccabue, M. Rossi, A. Vecchi, C. Tiezzi, V. Reverberi, C. Boarini, G. Abbati, M. Massari, P. Lampertico, G. Missale, C. Ferrari, P. Fisicaro
Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference
2023 M.G. Ghany, M. Buti, P. Lampertico, H.M. Lee
Hepatocellular carcinoma surveillance - utilization, barriers and the impact of changing aetiology
2023 D. Huang, A. Singal, F. Kanwal, P. Lampertico, M. Buti, C. Sirlin, M. Nguyen, R. Loomba
Profiling the risk of hepatocellular carcinoma after long-term HCV eradication in patients with liver cirrhosis in the PITER cohort
2023 L. A Kondili, M. Giovanna Quaranta, L. Cavalletto, V. Calvaruso, L. Ferrigno, R. D'Ambrosio, I. Simonelli, G. Brancaccio, G. Raimondo, M. R Brunetto, A. Linda Zignego, C. Coppola, A. Iannone, E. Biliotti, G. Verucchi, M. Massari, A. Licata, F. Barbaro, M. Persico, F. Paolo Russo, F. Morisco, M. Pompili, M. Viganò, M. Puoti, T. Santantonio, E. Villa, A. Craxì, L. Chemello, V. Panetta, G. Battista Gaeta, R. Filomia, B. Coco, M. Monti, D. Caterina Amoruso, S. Madonia, D. Ieluzzi, G. Taliani, L. Badia, G. Marco Migliorino, A. Giorgini, M. Masarone, P. Blanc, V. Cossiga, M. De Siena, X. Tata, M. Grazia Rumi, L. Chessa, P. Lampertico, C. Ferrari, I. Gentile, G. Parruti, L. Baiocchi, A. Ciancio, P. Invernizzi, A. Federico, C. Torti, G. Morsica, P. Andreone, A. Aghemo, P. Popoli, S. Vella
Long-term endoscopic surveillance in HBV compensated cirrhotic patients treated with Tenofovir or Entecavir for 11 years
2023 E. Farina, A. Loglio, G. Tosetti, E. Degasperi, M. Viganò, C. Gentile, S. Monico, R. Perbellini, M. Borghi, F. Facchetti, S. Uceda Renteria, F. Ceriotti, F. Cerini, M. Primignani, P. Lampertico
Chronic Hepatitis B Finite Treatment: Similar and Different Concerns With New Drug Classes
2023 M. G Peters, M. Yuen, N. Terrault, J. Fry, P. Lampertico, E. Gane, C. Hwang, L. M Stamm, M. Leus, M. K Maini, P. Mendez, I. Lonjon-Domanec, T. Berg, S. Wang, P. Mishra, E. Donaldson, S. Buchholz, V. Miller, O. Lenz
No virologic resistance to bulevirtide monotherapy detected in patients through 24 weeks treatment in phase II and III clinical trials for chronic hepatitis delta
2023 J. Hollnberger, Y. Liu, S. Xu, S. Chang, R. Martin, S. Manhas, T. Aeschbacher, B. Han, T. Yazdi, L. May, D. Han, A. Shornikov, J. Flaherty, D. Manuilov, V. Suri, T. Asselah, P. Lampertico, H. Wedemeyer, S. Aleman, C. Richards, R. Mateo, E. Maiorova, T. Cihlar, H. Mo, S. Urban
Hepatitis Delta: Ready for primetime?
2023 B. Maasoumy, P. Lampertico
Induced myocardial ischemia in candidates to liver transplantation without evidence of heart disease
2023 L. Mircoli, N. Bacà, B. Antonelli, L. Caccamo, E. Cattaneo, F. Colombo, C. Dibenedetto, L. Diehl, M.F. Donato, A. Faggiano, M.A. Iavarone, P. Lampertico, C. Marenghi, F. Polli, E. Quarenghi, F.B. Sozzi, C. Spaziani, G. Tosetti, C. Valsecchi, P. Vicardi, M. Vicenzi, A. Zefelippo, M. Ruscica, S. Carugo
Hepatitis D virus infection: Pathophysiology, epidemiology and treatment. Report from the first international delta cure meeting 2022
2023 P. Lampertico, E. Degasperi, L. Sandmann, H. Wedemeyer, C. Yurdaydin, D. Roulot, F. Zoulim, F.A. Caruntu, H. Kefalakes, J. Lucifora, K. Agarwal, L. Castera, M. Buti, M. Rizzetto, M. Cornberg, M. Dandri, M. Brunetto, N. Reau, R. Gish, S. Hamid, S. Aleman, S. Urban, T. Asselah, T. Berg, V. de Ledinghen
A 3-Year Course Of Bulevirtide Monotherapy May Cure Hdv Infection In Cirrhotics
2023 M.P. Anolli, E. Degasperi, L. Allweiss, A. Sangiovanni, M. Maggioni, C. Scholtes, V. Oberhardt, C. Neumann-Haefelin, M. Dandri, F. Zoulim, P. Lampertico
Bulevirtide‐based treatment strategies for chronic hepatitis delta: A review
2023 E. Degasperi, M.P. Anolli, P. Lampertico
Spike-specific humoral and cellular immune responses after COVID-19 mRNA vaccination in patients with cirrhosis: A prospective single center study
2023 M. Iavarone, G. Tosetti, F. Facchetti, M. Topa, J. Ming Er, S. Kit Hang, D. Licari, A. Lombardi, R. D'Ambrosio, E. Degasperi, A. Loglio, C. Oggioni, R. Perbellini, R. Caccia, A. Bandera, A. Gori, F. Ceriotti, L. Scudeller, A. Bertoletti, P. Lampertico